Versartis.com

Versartis. Inc. is an endocrine-focused biopharmaceutical company initially developing somavaratan, a novel, long-acting form of recombinant human...

What’s new on Versartis.com: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Versartis.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Versartis

Subscribe to related news

SuppVersity Science Round-Up Seconds: All About DHEA. Plus: In Practice - Supplementation Benefits & Dosages?
via suppversity.blogspot

A lack of libido appears - if at all - treatable w/ DHEA only in peri-menopausal women (Maggi. 2013; Pucchino. 2013); there are however a lot of other things DHEA can do for you. The power of electricity made it possible. Yesterday's show went really...
Where are we now with Gene Therapy?
via totalbiopharma

Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. If a mutated gene causes a necessary protein to be faulty or missing, gene therapy may be able to introduce a normal copy...
Deals of the Week Looks at Ultra-Orphan Drug Pricing
via invivoblog.blogspot

In the first half of 2013, two drugs will have launched in the US priced at $250,000 per patient annually: Both address serious, ultra-rare diseases and are backed by KOLs and patients. But the similarities stop there. Three months into its launch, one...
BI-836845 a fully human mAb targeting IGF-1 created using HuCAL technology from Morphosys, for the potential iv infusion...
via newdrugapprovals.wordpress

BI-836845 Human monoclonal IgG1 lambda antibody against IGF-1 (insulin growth factor-1) and IGF-2 IGF pathway modulator (iv, cancer), Boehringer Ingelheim; Phase 2 Clinical Anticancer protein kinase inhibitor; Anticancer monoclonal antibody WO...
InPlay from Briefing.com
via whotrades.olanola

------ Major European indices trade lower across the board with Germany's DAX (-2.0%) trailing the region. Elsewhere, European Central Bank member Benoit Coeure said that debt relief for Greece is no longer a subject of debate with bailout negotiations...

Versartis.com popular pages

Careers – Versartis Inc

be a company with a heart – Jay P. Shepard, President and CEO Empowered Employees. Innovation Without Boundaries. Meaningful Work. At Versartis, we are driven each day by our focus on patients who des...
Opportunities – Versartis Inc

If you are a motivated, hardworking person seeking to grow your career in the biotechnology industry while also making a meaningful difference for patients, we’d love to hear from you. The great thing...

J14VR5 Trial – Versartis Inc

J14VR5 Trial J14VR5 is a randomized, Phase 2/3, open-label, multi-center study of the pharmacokinetics (PK), pharmacodynamics (PD), safety and efficacy of a long-acting human growth hormone, somavarat...